pharma · Anemia · Anemia Associated With Chronic Kidney Disease · AKBA
Akebia Europe
Akebia Europe Limited
Akebia Europe clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2007
- Employees
- 271
- Programs
- 25
- Drugs
- 13
- Patents
- 28
Akebia Europe projects
6 ClinicalTrials.gov programs sponsored by Akebia Europe.
Akebia Europe has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AKB-6548
Akebia Europe Limited
Anemia
4 trials -
IW-1973
Akebia Europe Limited
Heart Failure With Preserved Ejection Fraction
1 trial -
IW-1973
Akebia Europe Limited
Type 2 Diabetes Mellitus With Diabetic Nephropathy
1 trial -
Praliciguat
Akebia Europe Limited
Focal Segmental Glomerulosclerosis
1 trial -
Vadadustat
Akebia Europe Limited
Chronic Kidney Disease
1 trial -
vadadustat
Akebia Europe Limited
Acute Respiratory Distress Syndrome
1 trial
Frequently asked questions
How many clinical projects does Akebia Europe have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.